Lleo A. SVR is the strongest predictor of occurrence and recurrence of hepatocellular carcinoma in HCV cirrhotic patients after treatment with DAAs: A prospective multi-centric Italian study. PS-154.
Bezlotoxumab ter preventie van recidiverende 'Clostridium difficile'-infecties
nov 2018 | Bacteriële infecties